Characterizing genetic risk at known prostate cancer susceptibility loci in African Americans
- PMID: 21637779
- PMCID: PMC3102736
- DOI: 10.1371/journal.pgen.1001387
Characterizing genetic risk at known prostate cancer susceptibility loci in African Americans
Abstract
GWAS of prostate cancer have been remarkably successful in revealing common genetic variants and novel biological pathways that are linked with its etiology. A more complete understanding of inherited susceptibility to prostate cancer in the general population will come from continuing such discovery efforts and from testing known risk alleles in diverse racial and ethnic groups. In this large study of prostate cancer in African American men (3,425 prostate cancer cases and 3,290 controls), we tested 49 risk variants located in 28 genomic regions identified through GWAS in men of European and Asian descent, and we replicated associations (at p≤0.05) with roughly half of these markers. Through fine-mapping, we identified nearby markers in many regions that better define associations in African Americans. At 8q24, we found 9 variants (p≤6×10(-4)) that best capture risk of prostate cancer in African Americans, many of which are more common in men of African than European descent. The markers found to be associated with risk at each locus improved risk modeling in African Americans (per allele OR = 1.17) over the alleles reported in the original GWAS (OR = 1.08). In summary, in this detailed analysis of the prostate cancer risk loci reported from GWAS, we have validated and improved upon markers of risk in some regions that better define the association with prostate cancer in African Americans. Our findings with variants at 8q24 also reinforce the importance of this region as a major risk locus for prostate cancer in men of African ancestry.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures



References
-
- Al Olama AA, Kote-Jarai Z, Giles GG, Guy M, Morrison J, et al. Multiple loci on 8q24 associated with prostate cancer susceptibility. Nat Genet. 2009;41:1058–1060. - PubMed
-
- Amundadottir LT, Sulem P, Gudmundsson J, Helgason A, Baker A, et al. A common variant associated with prostate cancer in European and African populations. Nat Genet. 2006;38:652–658. - PubMed
-
- Eeles RA, Kote-Jarai Z, Giles GG, Olama AA, Guy M, et al. Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet. 2008;40:316–321. - PubMed
Publication types
MeSH terms
Grants and funding
- RC2 CA148085/CA/NCI NIH HHS/United States
- CA88164/CA/NCI NIH HHS/United States
- N01-PC-35139/PC/NCI NIH HHS/United States
- R01 CA092447/CA/NCI NIH HHS/United States
- N01 PC035139/CA/NCI NIH HHS/United States
- U58 DP000807/DP/NCCDPHP CDC HHS/United States
- CA148085/CA/NCI NIH HHS/United States
- R01 CA063464/CA/NCI NIH HHS/United States
- R01 CA082664/CA/NCI NIH HHS/United States
- S06 GM008016/GM/NIGMS NIH HHS/United States
- R01 ES011126/ES/NIEHS NIH HHS/United States
- R01 CA092579/CA/NCI NIH HHS/United States
- U01 HG004726/HG/NHGRI NIH HHS/United States
- ES011126/ES/NIEHS NIH HHS/United States
- CA54281/CA/NCI NIH HHS/United States
- CA1326792/CA/NCI NIH HHS/United States
- P50 CA140388/CA/NCI NIH HHS/United States
- 1U58DP000807-3/DP/NCCDPHP CDC HHS/United States
- P30 CA68485/CA/NCI NIH HHS/United States
- R01 CA068578/CA/NCI NIH HHS/United States
- HG004726/HG/NHGRI NIH HHS/United States
- R01 CA056678/CA/NCI NIH HHS/United States
- CA63464/CA/NCI NIH HHS/United States
- R01 CA054281/CA/NCI NIH HHS/United States
- U01 CA063464/CA/NCI NIH HHS/United States
- ImNIH/Intramural NIH HHS/United States
- P30 CA068485/CA/NCI NIH HHS/United States
- R01 CA088164/CA/NCI NIH HHS/United States
- P50-CA140388/CA/NCI NIH HHS/United States
- CA092447/CA/NCI NIH HHS/United States
- R37 CA054281/CA/NCI NIH HHS/United States
- S06GM08016/GM/NIGMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical